文献速递血栓与止血

RNA测序揭示免疫性血小板减少症中独特的血小板转录组变化

RNA sequencing indicates distinct platelet transcriptomic changes in immune thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2026-07-04

本研究对活动性ITP、化疗所致血小板减少症、无治疗缓解期ITP及健康对照的血小板进行总RNA测序,发现活动性ITP血小板RNA总量升高,转录组以血小板活化通路上调为主,线粒体生物合成与氧化磷酸化基因下调;活化相关转录本的协同上调为活动性ITP所特有,缓解期部分正常化。

要点

  • 活动性ITP血小板RNA总量升高,提示年轻血小板比例增加。
  • 活动性ITP血小板活化通路协同上调,而线粒体基因表达下调。
  • 活化转录本协同上调为活动性ITP特有,有别于非ITP血小板减少。

核心结论

  • 活动性ITP血小板呈现活化通路协同上调、线粒体基因表达下调的独特转录组特征,提示活化预备且代谢改变的状态。

研究设计与样本

  • 对纯化血小板行总RNA测序:活动性ITP 6例、化疗所致血小板减少症6例、无治疗缓解期ITP 6例、健康对照8例。

主要发现

  • 活动性ITP血小板总RNA含量较高,与年轻、近期释放血小板富集一致。
  • 活动性ITP转录组以整合素和钙依赖信号、细胞骨架重塑、囊泡运输等活化通路为主。
  • 线粒体生物合成和氧化磷酸化基因下调,线粒体来源RNA比例降低。
  • 活动性与化疗所致血小板减少症RNA含量均高于健康对照,但活化转录本协同上调仅见于活动性ITP。
  • 无治疗缓解期ITP转录谱部分正常化,活化特征消失,表达介于活动性ITP与健康对照之间。

临床怎么用

  • 血小板转录组特征可能辅助区分活动性ITP与非ITP血小板减少。
  • 活化通路和线粒体基因表达谱或可反映ITP疾病活动度及缓解状态。

局限性

  • 各组样本量较小(6–8例),需更大样本验证。
  • 原文未报告具体差异表达基因数、P值或阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In immune thrombocytopenia (ITP), platelet-intrinsic alterations and their potential contribution to disease pathogenesis remain incompletely understood. Since platelets, although anucleate, retain a functional transcriptome, transcriptomic profiling may provide insight into disease-associated changes. OBJECTIVES: To investigate platelet-intrinsic transcriptomic changes in ITP and to determine whether these alterations are disease-specific compared with non-ITP. METHODS: Total RNA sequencing was performed on purified platelets from patients with active ITP (n = 6), chemotherapy-induced thrombocytopenia as a non-ITP control (n = 6), ITP in treatment-free remission (n = 6), and healthy controls (n = 8). RESULTS: Platelets from patients with active ITP exhibited higher total RNA content, consistent with enrichment of young, recently released platelets. Transcriptomic analysis identified a profile dominated by platelet activation pathways, including integrin- and calcium-dependent signaling, cytoskeletal remodeling, and vesicle trafficking. In contrast, genes involved in mitochondrial biogenesis and oxidative phosphorylation were downregulated, accompanied by a reduced proportion of mitochondrial-derived RNA. Although both active ITP and chemotherapy-induced thrombocytopenia showed elevated RNA content relative to healthy controls, reflecting enhanced platelet turnover, the coordinated upregulation of activation-associated transcripts was unique to active ITP. Platelets from ITP patients in treatment-free remission showed partial normalization of the transcriptional profile, with loss of the activation signature and intermediate expression patterns between active ITP and healthy controls. CONCLUSION: RNA sequencing data show distinct platelet transcriptomic changes in ITP, marked by coordinated upregulation of platelet activation pathways and reduced mitochondrial gene expression. This profile is consistent with an activation-primed, metabolically altered platelet state and may reflect disease-related changes in platelet biology in ITP.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Georgi JA, Hartwig M, Friedrich UA, et al. RNA sequencing indicates distinct platelet transcriptomic changes in immune thrombocytopenia. J Thromb Haemost. 2026. PMID: 42401324. doi:10.1016/j.jtha.2026.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。